Alessandra Pavesio - Mar 14, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
Fmr. SVP & Chief Science Off.
Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
4/21/2023, 05:05 PM
Previous filing
Feb 16, 2022
Next filing
Apr 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +35.5K $0.00 35.5K Mar 14, 2022 Class A Common Stock 35.5K Direct F1, F2
transaction BVS Stock Option (Right to Buy) Award $0 +96.1K $0.00 96.1K Mar 14, 2022 Class A Common Stock 96.1K $1.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.